1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Neurodegenerative Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berger, J; Dorninger, F; Forss-Petter, S; Wimmer, I | 1 |
| Bazan, NG | 1 |
2 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Neurodegenerative Diseases
| Article | Year |
|---|---|
Plasmalogens, platelet-activating factor and beyond - Ether lipids in signaling and neurodegeneration.
Topics: Animals; Humans; Neurodegenerative Diseases; Plasmalogens; Platelet Activating Factor; Signal Transduction | 2020 |
The neuromessenger platelet-activating factor in plasticity and neurodegeneration.
Topics: Animals; Cyclooxygenase 2; Glutamic Acid; Hippocampus; Humans; Isoenzymes; Membrane Proteins; Neurodegenerative Diseases; Neuronal Plasticity; Neurons; Neurotransmitter Agents; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Prostaglandin-Endoperoxide Synthases; Second Messenger Systems; Seizures; Signal Transduction; Synapses; Transcriptional Activation | 1998 |